Clinical and animal experiments concerning the function of brain catecholamines.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000096:biosynthesis / Q000502:physiology*; D002986:Clinical Trials as Topic; D003863:Depression / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D005556:Form Perception / Q000187:drug effects; D006801:Humans; D008094:Lithium / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D010293:Pargyline / Q000494:pharmacology; D010919:Placebos; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012559:Schizophrenia / Q000097:blood; D012701:Serotonin / Q000502:physiology; D013268:Stimulation, Chemical; D013997:Time Factors; D014443:Tyrosine / Q000097:blood
D000928:Antidepressive Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D012701:Serotonin; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D012110:Reserpine; D008094:Lithium; D010293:Pargyline; D004298:Dopamine; D009638:Norepinephrine